2026-05-22T00:46:42Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/85882025-04-10T12:22:09Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Oteo-Iglesias, Jesus author Saez, David author Bautista, Veronica author Fernandez-Romero, Sara author Hernández-Molina, Juan Manuel author Perez-Vazquez, Maria author Aracil, Belen author Campos, Jose author 2013-12 We report the epidemiological impact of carbapenemase-producing Enterobacteriaceae (CPE) in Spain in 2012. Of the 237 carbapenemases detected, 163 were from the OXA-48 group, 60 were from VIM-1, 8 were from KPC-2, 5 were from IMP, and 1 was from NDM-1. Interhospital spread of carbapenemase-producing Klebsiella pneumoniae was due to a limited number of multilocus sequence types (MLST) and carbapenemase types, including ST15-VIM-1, ST11-OXA-48, ST405-OXA-48, ST101-KPC-2, and ST11-VIM-1. The number of CPE cases in Spain has increased sharply in recent years, due mainly to the emergence of OXA-48. Antimicrob Agents Chemother. 2013 Dec;57(12):6344-7. 10.1128/AAC.01513-13 1098-6596 0066-4804 Antimicrobial agents and chemotherapy 24041898 http://hdl.handle.net/20.500.12105/8588 Carbapenemase-producing enterobacteriaceae in Spain in 2012